Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin in Adults with Prader-Willi Syndrome
NCT02804373Phase 3Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Jun 2014
- Primary completion
- Jan 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of oxytocin in Prader-Willi syndrome (PWS), sponsored by Centre hospitalier universitaire de Toulouse. Started Jun 2014; status: completed.
02
Drugs
oxytocin
03
Conditions
Prader-Willi syndrome (PWS)
Beyond the preview
Go deeper on NCT02804373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02804373.